Medpace: Impressive Revenue Growth, High ROE Values, And High Growth Potential
Medpace demonstrates strong financial performance and growth in the CRO market, despite facing challenges in the short term.
‘Why Trump’s attempts to reduce access to life-saving HIV medicine are a global catastrophe’
"Through remembering the dead to fight like hell for the living - we act up and fight back!" writes Dan Glass of his response ...
60 Degrees Pharma Announces Closing of $1.075 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
The aggregate gross proceeds to the Company from the offering were approximately $1.075 million, before deducting the placement agent fees and other offering expenses payable by the Company. The total ...
Eton Pharmaceuticals Announces Extension of PDUFA Goal Date for ET-400
The FDA communicated that it has applied a standard three-month extension from the original goal date of February 28, 2025. Eton believes it has fully addressed all questions from the FDA and there ...
Trump Faces Pressure From US Industry Over China Tariff on Medicines
(Reuters) - President Donald Trump is facing pressure from U.S. hospitals and generic drugmakers to exempt medical goods from ...
Where Tariffs Will Hit Hardest
While Trump’s threatened duties would generate significant tax revenue, they could also hurt the broader economy.
Trump’s trade war threats trigger alarm in Australian ruling circles
While Trump has not yet specifically targeted imports from Australia, his offensive has profoundly destabilising economic and ...
Updated drug information handout outdoes FDA's version in clinical trial
A clinical trial comparing a one-page medication handout proposed by the U.S. Food and Drug Administration (FDA) with an ...